– Breast carcinomas
– Ovarian cancers
– Oesophagus, stomach, pancreas and hepatocellular cancer
– Non-Hodgkin lymphoma
– SCLC
– Soft tissue sarcomas
Administered intravesically in:
– Papillary transitional cell carcinoma of the bladder
– Carcinoma-in-situ of the bladder
– Prophylaxis of recurrences after transurethral resection